Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases.

Çakan M., Karadağ Ş. G., Ayaz N.

The Turkish journal of pediatrics, cilt.62, ss.167-174, 2020 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 62
  • Basım Tarihi: 2020
  • Doi Numarası: 10.24953/turkjped.2020.02.001
  • Dergi Adı: The Turkish journal of pediatrics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.167-174
  • Anahtar Kelimeler: autoinflammatory diseases, canakinumab, colchicine resistant familial Mediterranean fever, MEVALONATE KINASE, EFFICACY, RECOMMENDATIONS, MANAGEMENT, CRITERIA, CHILDREN
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Background and objectives. The aim of this observational retrospective cohort study was to demonstrate indications and response rates of the patients with pediatric rheumatic diseases that used canakinumab.